SPDR Gold Trust vs TransMedics Group Inc — how do they compare? SPDR Gold Trust trades at $367.24, while TransMedics Group Inc trades at $77.43 (market cap $2.61B). The key difference: SPDR Gold Trust is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| GLD | TMDX | |
|---|---|---|
52-Week High | $495.90 | $150.42 |
52-Week Low | $300.96 | $61.99 |
Market Cap | — | $2.61B |
Sector | — | Technology |
Enterprise Value | — | $3.01B |
Signals from Pluang's Aura AI — not financial advice
GLD, tracking physical gold prices, trades at $365.98, down 1.66% amid a bearish technical signal with moving averages indicating selling pressure. Recent U.S. economic data, including jobless claims and inflation figures, influence gold's short-term volatility, while central bank accumulation provides underlying support. The ETF lacks traditional financial ratios as it holds bullion, with performance tied directly to gold market dynamics and macroeconomic factors.
The outlook for GLD hinges on gold's response to Federal Reserve policy and geopolitical tensions, offering a hedge against inflation but facing headwinds from a stronger dollar and rising yields. Risks include interest rate sensitivity and market sentiment shifts, with investors monitoring key resistance near $375 for breakout potential.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →